Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy

European Heart Journal

Volumn 32, Issue 9, 2011, Pages 1114-1120

  Johnson, Jonathan N ^a   Grifoni, Camilla ^b   Bos, J Martijn ^c   Saber Ayad, Maha ^b   Ommen, Steve R ^a   Nistri, Stefano ^b   Cecchi, Franco ^b   Olivotto, Iacopo ^b   Ackerman, Michael J ^a,c  

^a MAYO CLINIC   (United States)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

Hypertrophic cardiomyopathy; Long QT syndrome; QT interval; Sudden death; Ventricular arrhythmia

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FAMILY HISTORY; FEMALE; GENDER; GENOTYPE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RETROSPECTIVE STUDY; SUDDEN DEATH; CARDIOVERSION; CLINICAL TRIAL; HEART OUTFLOW TRACT OBSTRUCTION; INSTRUMENTATION; LONG QT SYNDROME; MIDDLE AGED; MULTICENTER STUDY; PROGNOSIS;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; GENOTYPE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; VENTRICULAR OUTFLOW OBSTRUCTION; YOUNG ADULT;

EID: 79955738116     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr021     Document Type: Article

References (27)

1. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287: 1308-1320. (Pubitemid 34250486)
2. Bos JM, Towbin JA, Ackerman MJ. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol 2009; 54:201-211.
3. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA 3rd, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007;298:405-412. (Pubitemid 47124061)
4. McKenna WJ, Goodwin JF. The natural history of hypertrophic cardiomyopathy. Curr Probl Cardiol 1981;6:1-26.
5. Spirito P, Autore C, Rapezzi C, Bernabo P, Badagliacca R, Maron MS, Bongioanni S, Coccolo F, Estes NA, Barilla CS, Biagini E, Quarta G, Conte MR, Bruzzi P, Maron BJ. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation 2009;119:1703-1710.
6. Kofflard MJ, Ten Cate FJ, van der Lee C, van Domburg RT. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol 2003;41:987-993. (Pubitemid 36315542)
7. Cecchi F, Maron BJ, Epstein SE. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. J Am Coll Cardiol 1989;13:1283-1288. (Pubitemid 19114200)
8. McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981;47:532-538. (Pubitemid 11137648)
9. Goldenberg I, Moss AJ, Peterson DR, McNitt S, Zareba W, Andrews ML, Robinson JL, Locati EH, Ackerman MJ, Benhorin J, Kaufman ES, Napolitano C, Priori SG, Qi M, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation 2008;117:2184-2191.
10. Goldenberg I, Moss AJ, Bradley J, Polonsky S, Peterson DR, McNitt S, Zareba W, Andrews ML, Robinson JL, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Qi M, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Long-QT syndrome after age 40. Circulation 2008;117:2192-2201.
11. Hobbs JB, Peterson DR, Moss AJ, McNitt S, Zareba W, Goldenberg I, Qi M, Robinson JL, Sauer AJ, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Towbin JA, Vincent GM, Zhang L. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA 2006;296:1249-1254. (Pubitemid 44394896)
12. Sauer AJ, Moss AJ, McNitt S, Peterson DR, Zareba W, Robinson JL, Qi M, Goldenberg I, Hobbs JB, Ackerman MJ, Benhorin J, Hall WJ, Kaufman ES, Locati EH, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Long QT syndrome in adults. J Am Coll Cardiol 2007;49:329-337. (Pubitemid 46097383)
13. Seth R, Moss AJ, McNitt S, Zareba W, Andrews ML, Qi M, Robinson JL, Goldenberg I, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Long QT syndrome and pregnancy. J Am Coll Cardiol 2007;49:1092-1098. (Pubitemid 46349501)
14. Chugh SS, Reinier K, Singh T, Uy-Evanado A, Socoteanu C, Peters D, Mariani R, Gunson K, Jui J. Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study. Circulation 2009;119:663-670.
15. Kenigsberg DN, Khanal S, Kowalski M, Krishnan SC. Prolongation of the QTc interval is seen uniformly during early transmural ischemia. J Am Coll Cardiol 2007;49:1299-1305. (Pubitemid 46467228)
16. Jouven X, Hagege A, Charron P, Carrier L, Dubourg O, Langlard JM, Aliaga S, Bouhour JB, Schwartz K, Desnos M, Komajda M. Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy. Heart 2002; 88:153-157. (Pubitemid 34787768)
17. Martin AB, Garson A Jr., Perry JC. Prolonged QT interval in hypertrophic and dilated cardiomyopathy in children. Am Heart J 1994;127:64-70. (Pubitemid 24040431)
18. Uchiyama K, Hayashi K, Fujino N, Konno T, Sakamoto Y, Sakata K, Kawashiri MA, Ino H, Yamagishi M. Impact of QT variables on clinical outcome of genotyped hypertrophic cardiomyopathy. Ann Noninvasive Electrocardiol 2009;14:65-71.
19. Olivotto I, Girolami F, Ackerman MJ, Nistri S, Bos JM, Zachara E, Ommen SR, Theis JL, Vaubel RA, Re F, Armentano C, Poggesi C, Torricelli F, Cecchi F. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. Mayo Clin Proc 2008;83:630-638. (Pubitemid 351810562)
20. Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, Gersh BJ, Ackerman MJ. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;44:1903-1910. (Pubitemid 39424094)
21. Crow RS, Hannan PJ, Folsom AR. Prognostic significance of corrected QT and corrected JT interval for incident coronary heart disease in a general population sample stratified by presence or absence of wide QRS complex: the ARIC Study with 13 years of follow-up. Circulation 2003;108:1985-1989. (Pubitemid 37296543)
22. Bazett H. An analysis of the time-relations of electrocardiograms. Heart 1920;7: 353-370.
23. Mason JW, Ramseth DJ, Chanter DO, Moon TE, Goodman DB, Mendzelevski B. Electrocardiographic reference ranges derived from 79, 743 ambulatory subjects. J Electrocardiol 2007;40:228-234.
24. Taggart NW, Haglund CM, Tester DJ, Ackerman MJ. Diagnostic miscues in congenital long-QT syndrome. Circulation 2007;115:2613-2620. (Pubitemid 46791359)
25. Johnson JN, Ackerman MJ. QTc: how long is too long? Br J Sports Med 2009;43: 657-662.
26. Talbot S. QT interval in right and left bundle-branch block. Br Heart J 1973;35: 288-291.
27. Maron BJ, Leyhe MJ 3rd, Casey SA, Gohman TE, Lawler CM, Crow RS, Maron MS, Hodges M. Assessment of QT dispersion as a prognostic marker for sudden death in a regional nonreferred hypertrophic cardiomyopathy cohort. Am J Cardiol 2001; 87:114-115, A9. (Pubitemid 32013097)